Symposia: Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Apoptosis, Translational Research, Lymphomas, Drug development, Bispecific Antibody Therapy, Non-Hodgkin lymphoma, B Cell lymphoma, Diseases, Indolent lymphoma, Aggressive lymphoma, Treatment Considerations, Biological therapies, Immunology, Lymphoid Malignancies, Non-Biological therapies, Biological Processes, Pharmacology, Molecular biology, Technology and Procedures, Study Population, Pathogenesis, Animal model, Omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Apoptosis, Translational Research, Lymphomas, Drug development, Bispecific Antibody Therapy, Non-Hodgkin lymphoma, B Cell lymphoma, Diseases, Indolent lymphoma, Aggressive lymphoma, Treatment Considerations, Biological therapies, Immunology, Lymphoid Malignancies, Non-Biological therapies, Biological Processes, Pharmacology, Molecular biology, Technology and Procedures, Study Population, Pathogenesis, Animal model, Omics technologies
Monday, December 9, 2024: 4:30 PM-6:00 PM
Ballroom 20CD
(San Diego Convention Center)
Moderators:
Markus Müschen, MD, Yale University
and
Piers Blombery, MBBS, Peter Maccallum Cancer Centre
Disclosures:
No relevant conflicts of interest to declare.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH